Evidence map›Paper›PMID 42378063›Full record

ArticleJCI insight2026

Reduced peroxisomal function increases insulin secretion, promotes insulin oxidation, and impairs β cell maturity.

J Jason Collier, Caroline R Cothern, Maggie P Ducote, Thomas M Martin, Melissa A Linden, Robert C Noland, David H Burk, Samuel D Dupuy, Michael D Karlstad, Krisztian Stadler and 11 more

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

J Jason CollierPennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Caroline R CothernPennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Maggie P DucotePennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Thomas M MartinPennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Melissa A LindenPennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Robert C NolandPennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
David H BurkPennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Samuel D DupuyDepartment of Surgery, The University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, USA.
Michael D KarlstadDepartment of Surgery, The University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, USA.
Krisztian StadlerPennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Sarah S HirschbeckDepartment of Chemistry, The University of Tennessee Knoxville, Tennessee, USA.
Thanh D DoDepartment of Chemistry, The University of Tennessee Knoxville, Tennessee, USA.
Anastasia ColdrenDepartment of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Marcela BrissovaDepartment of Medicine, Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Teayoun KimComprehensive Diabetes Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kirk M HabeggerComprehensive Diabetes Center, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Sujoy GhoshPennington Biomedical Research Center, Baton Rouge, Louisiana, USA.
Zane A VickeryDepartment of Chemistry, The University of Tennessee Knoxville, Tennessee, USA.
Qudus SarumiDepartment of Chemistry, The University of Tennessee Knoxville, Tennessee, USA.
Shawn R CampagnaDepartment of Chemistry, The University of Tennessee Knoxville, Tennessee, USA.
Susan J BurkePennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI ROBERT A KESTERSON · 2005 to 2026
$26.5M
The role of maternal obesity-driven inflammation and adverse pregnancy outcomes in a mouse model of preeclampsiaP20GM135002 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Jacqueline M Stephens · 2020 to 2026
$18.4M
SGK1 is a regulator of islet beta cell mass and secretory functionR01DK123183 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI COLLIER, JAMES JASON · 2020 to 2024
$1.8M
Novel redox mechanisms of oxygenated phospholipids in chronic and diabetic kidney diseaseR01DK137472 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI STADLER, KRISZTIAN · 2023 to 2025
$888k
Sable Systems Promethion for Mouse Metabolic AnalysisS10OD023703 · OD · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI MORRISON, CHRISTOPHER D · 2017 to 2017
$626k
Mechanisms of glucocorticoid-induced metabolic dysfunction in skeletal muscleR56DK141177 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI COLLIER, JAMES JASON, NOLAND, ROBERT CHARLES · 2024 to 2024
$113k
NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK123183NIDDK NIH HHS R01 DK137472NIDDK NIH HHS R56 DK141177NIGMS NIH HHS P20 GM135002NIH HHS S10 OD023703
6 · The paper itself

Abstract

Given the central role of peroxisomes in lipid metabolism and redox homeostasis, we hypothesized that peroxisomal activity is critical for sustaining β cell function and identity. Pex5 deletion models were employed to investigate the loss of peroxisomal function on glucose-stimulated insulin secretion (GSIS), oxidative stress, and β cell maturity markers. Peroxisome deficiency in male mice resulted in elevated GSIS. Glucose intolerance developed despite increased insulin secretion. Ion mobility mass spectrometry revealed oxidation of insulin proteins and a truncated insulin 2-derived peptide in islets from mice with a tissue-specific deficiency in peroxisomes. Peroxisome loss of function increased multiple markers of oxidative stress, including altered metabolite profiles, lipid peroxidation, and protein carbonylation. These findings revealed that increased secretion of oxidized insulin protein is insufficient to regulate whole-body glucose homeostasis. Peroxisome deficiency also reduced markers of β cell maturity. Based on these outcomes, we identified the peroxisome organelle as a key regulatory component of glucose homeostasis by protecting insulin from oxidative modification and degradation and by supporting maintenance of mature β cells.

Indexed as

InsulinInsulin-Secreting CellsInsulin SecretionPeroxisomesAnimalsGlucoseGlucose IntoleranceMaleMiceMice, KnockoutOxidation-ReductionOxidative StressPeroxisome-Targeting Signal 1 ReceptorGlucoseInsulinPeroxisome-Targeting Signal 1 ReceptorPex5 protein, mouseEndocrinologyFatty acid oxidationInsulinIslet cellsMetabolism

Identifiers

PMID42378063
PMCPMC13463611

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.